PULMONARY TUBERCULOSIS AND ASSOCIATED PATHOLOGIES – PROBLEMS OF COMORBIDITY, PATHOGENESIS, AND PATIENT MANAGEMENT
Keywords:
tuberculosis, comorbidities, atypical courseAbstract
Tuberculosis (TB) remains one of the leading causes of infectious disease mortality worldwide. Current research convincingly demonstrates that the outcome and epidemiology of pulmonary tuberculosis are inextricably linked to the presence of comorbidities. This review examines key comorbid conditions in TB, their impact on pathogenesis, diagnosis, treatment, and disease outcomes, and highlights the need for an integrated approach to the management of these patients.
References
Lönnroth K., et al. (2015). A framework for collaborative action on tuberculosis and comorbidities. The European Respiratory Journal , 45(1), 1–4.
Pawlowski A., et al. (2012). Tuberculosis and HIV co-infection. PLoS Pathogens , 8(2), e1002464.
World Health Organization. (2021). Consolidated guidelines on tuberculosis: Module 4: Treatment: Drug-resistant tuberculosis treatment.
Restrepo B.I. (2016). Diabetes and Tuberculosis. Microbiology Spectrum , 4(6).
Degner N.R., et al. (2018). Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment. Clinical Infectious Diseases , 66(2), 198–205.
Byrne A.L., et al. (2015). Tuberculosis and chronic respiratory disease: a systematic review. International Journal of Infectious Diseases , 32, 138–146.
Dobler C.C., et al. (2017). Burden of tuberculosis and serious comorbidities: a retrospective matched cohort study. BMC Infectious Diseases , 17, 112.
Tiberi S., et al. (2018). Managing tuberculosis and liver disease. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases , 13, 1–6.
Tuberculosis and chronic respiratory disease: a systematic review, Anthony L Byrne 1, Ben J Marais 2, Carole D Mitnick 3, Leonid Lecca 4, Guy B Marks 5
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD). Janjua S, Carter D, Threapleton CJ, Prigmore S, Disler RT. Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196.
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Chong J, Karner C, Poole P. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157.
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S, Mathioudakis AG, Fortescue R, Walker RA, Sharif S, Threapleton CJ, Dias S. Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198.
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381.
